![Douglas Blankenship](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Blankenship
Plus aucun poste en cours
Profil
Douglas L.
Blankenship currently works at Holdco Nuvo Group DG Ltd., as Chief Financial Officer from 2024.
Mr. Blankenship also formerly worked at Genentech, Inc., as Director-Global Quality, Compliance & Technical from 2006 to 2015, Roche Pharmaceuticals, Inc., as Director-Global Quality & Compliance from 2008 to 2015, Amgen Technology (Ireland) Unlimited Co., as Finance Director from 2006 to 2008, Virage Logic Corp., as Finance Director, Humacyte Global, Inc., as Chief Financial Officer, and Dova Pharmaceuticals, Inc., as CFO & Principal Accounting Officer from 2017 to 2018.
Mr. Blankenship received his undergraduate degree from California Polytechnic State University (San Luis Obispo) and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Douglas Blankenship
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Douglas Blankenship
| Sociétés | Poste | Fin |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Directeur Financier/CFO | 19/05/2021 |
| DOVA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 31/01/2018 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Compliance Officer | 01/10/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/10/2015 |
Amgen Technology (Ireland) Unlimited Co.
 Amgen Technology (Ireland) Unlimited Co. Medical/Nursing ServicesHealth Services Provides health care services | Directeur Financier/CFO | 01/01/2008 |
Formation de Douglas Blankenship
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Virage Logic Corp.
 Virage Logic Corp. SemiconductorsElectronic Technology Provides embedded memory technology solutions | Electronic Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Amgen Technology (Ireland) Unlimited Co.
Amgen Technology (Ireland) Unlimited Co. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
